Navigation Links
Lack of sleep among new school-goers leads to behavioral, cognitive problems
Date:9/1/2007

WESTCHESTER, Ill. The first investigation of developmental sleep duration patterns throughout childhood shows that children just beginning school and who get little sleep are more likely to have behavioral and cognitive problems in the classroom, according to a study published in the September 1 issue of the journal SLEEP.

The study, authored by Jacques Montplaisir, MD, of the Sleep Disorders Center at Sacre-Coeur Hospital in Montreal, Quebec, Canada, focused on 1,492 children, who were studied annually from five months of age to six years. A questionnaire, filled out by the childrens mothers, measured each childs hyperactivity-impulsivity (HI), inattention and daytime sleepiness scores for each of those years.

Four developmental sleep duration patterns were identified in the study: short persistent (six percent), composed of children sleeping less than 10 hours per night until the age of 6 years; short increasing (4.8 percent), composed of children who slept fewer hours in early childhood but whose sleep duration increased around 41 months of age; 10-hour persistent (50.3 percent), composed of children who slept persistently approximately 10 hours per night; and 11-hour persistent (38.9 percent), composed of children who slept persistently around 11 hours each night.

According to Dr. Montplaisir, the study found no difference in sleep duration between weekdays and weekends, indicating that children were not compensating on the weekend for sleep loss occurring during the week, even in the group of short persistent sleepers. Short increasing sleepers, who had evidence of a nocturnal sleep consolidation problem before the age of 41 months, did not compensate their short nighttime sleep duration by more daytime sleep at 29 months, added Dr. Montplaisir.

The results indicate that a modest but chronic reduction of just one hour of sleep nightly in early childhood can affect the childs cognitive performance at school entry. Sho
'/>"/>

Contact: Jim Arcuri
jarcuri@aasmnet.org
708-492-0930
American Academy of Sleep Medicine
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Good sleep enhances task performance
2. Individuals with sleep related breathing disorders more prone to heart disease
3. Sleep apnoea increases post-operative risks
4. Sleep, snoring....stroke
5. Sleeping sickness - a silent killer
6. Deep Sleep Doesnt Increase Memory
7. Deprived sleep leads to ageing
8. Cure for sleepless nights
9. Warm yourself to sleep
10. Genetic disorder related with sleep patterns
11. Sleep apnoea linked to surgical risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)...re-FirstCall/ -- The Board of Directors of Tyco In...ared a regular quarterly cash dividend of $0.20 pe...ry 2, 2009, to shareholders of record as of Januar..., Tyco International (NYSE: TYC ) is a divers... and services to customers in more than 60 countri...
(Date:12/4/2008)... the wake of the findings of its 5th,Internationa...dvances in,nutrition and its importance in elite ...esearch program on the specific nutritional needs ... The program will provide data to help,support a ...the future, which,should lead to a new generation...
(Date:12/4/2008)...studies into the practice of forcing psychiatric p...w showed that there have been very few rigorous in...blished in the latest Journal of Advanced Nursing...tion (CM) are more likely to be in their thirties ...r or another psychotic disorder. , CM is used m...
(Date:12/4/2008)...Stem cells derived from bone marrow may serve as a...ed epidermolysis bullosa (EB), a disorder charact...to a study prepublished online in Blood , the o...ogy. Epidermolysis bullosa is a disorder charac...ering on touch, akin to third degree burns. While ...
Breaking Medicine News(10 mins):Health News:Nestle Launches New Research Program on the Specific Nutritional Needs of Athletes 2Health News:Nestle Launches New Research Program on the Specific Nutritional Needs of Athletes 3Health News:Coerced medication used in psychiatric care despite lack of clinical evidence 2Health News:Coerced medication used in psychiatric care despite lack of clinical evidence 3Health News:Bone marrow-derived stem cells may offer novel therapeutic option for skin disorder 2Health News:Bone marrow-derived stem cells may offer novel therapeutic option for skin disorder 3
...la virus in its latest outbreak has claimed around...istry officials in Kampala. More shocking is the ...luding doctors & nurses. But what shocked the nat... a prominent doctor spearheading the fight against...
, which is a much talked about topic, considering that the mapping of the genes will enable one to have the information to manipulate individual characteristics like the color of the eye or even skin.
...he December issue of the Journal of Infectious Dis...peripheral blood mononuclear cells (PBMCs) from in...ed to PBMCs from infected patients treated with an...th and her team at the National Institute of Aller...
... the heart attack patients should get an immediate...ood flow to their hearts. Cleveland Clinic cardio...of more than 12,000 heart disease patients and fou...l count is in what is considered a "high normal ra...
Other Medicine News:
(Date:12/2/2008)...Dec. 2 Biopure Corporati.... Naval Medical Research Center,(NMRC) has submit...vised,investigational new drug (IND) application ...en therapeutic Hemopure(R) [hemoglobin glutamer - ...eatment of trauma patients. The study is,entitled...
(Date:12/1/2008)...RNewswire-USNewswire/ -- New research has found th...uted tomography (CT) scanner in an emergency room ...ctims who receive a potentially life-saving treatm...e Medical Center (NSMC)-Salem Hospital in Salem, M...g of the Radiological Society of North America (RS...
(Date:12/1/2008)... 1 Roche announced today that a,c... in perceived pain and,discomfort associated with...cose monitoring systems and lancing devices were d...at, overall, the ACCU-CHEK Aviva and ACCU-CHEK Com...e ACCU-CHEK Multiclix, ACCU-CHEK,Softclix and ACC...
(Date:12/1/2008)...mark, December 1 Followi... intent to procure an MVA-based,third generation...vices,Canada, on behalf of the Canadian Departmen...Bavarian Nordic for the delivery of IMVAMUNE(R). ,...AMUNE(R) as part of the,country,s bio-preparednes...
Breaking Medicine Technology:U.S. Naval Medical Research Center Resubmits IND Application for Proposed 'Op RESUS' Clinical Trial in Trauma Patients in the Battlefield Setting 2U.S. Naval Medical Research Center Resubmits IND Application for Proposed 'Op RESUS' Clinical Trial in Trauma Patients in the Battlefield Setting 3Portable CT Increases Chance of Stroke Survival and Recovery 2Portable CT Increases Chance of Stroke Survival and Recovery 3Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful 2Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful 3The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3New Anti Cellulite Treatment Prepares Women for Falls Short Skirts 25116 1New Anti Cellulite Treatment Prepares Women for Falls Short Skirts 25116 2New Anti Cellulite Treatment Prepares Women for Falls Short Skirts 25116 3MedCath Corporation Reports Third Quarter Earnings 25112 1MedCath Corporation Reports Third Quarter Earnings 25112 2MedCath Corporation Reports Third Quarter Earnings 25112 3MedCath Corporation Reports Third Quarter Earnings 25112 4MedCath Corporation Reports Third Quarter Earnings 25112 5MedCath Corporation Reports Third Quarter Earnings 25112 6MedCath Corporation Reports Third Quarter Earnings 25112 7MedCath Corporation Reports Third Quarter Earnings 25112 8MedCath Corporation Reports Third Quarter Earnings 25112 9MedCath Corporation Reports Third Quarter Earnings 25112 10MedCath Corporation Reports Third Quarter Earnings 25112 11MedCath Corporation Reports Third Quarter Earnings 25112 12MedCath Corporation Reports Third Quarter Earnings 25112 13MedCath Corporation Reports Third Quarter Earnings 25112 14MedCath Corporation Reports Third Quarter Earnings 25112 15MedCath Corporation Reports Third Quarter Earnings 25112 16Ortho McNeil initiates first of its kind skin infection registry 25110 1Ortho McNeil initiates first of its kind skin infection registry 25110 2Interleukin Genetics Announces Conference Call and Webcast to Discuss Second Quarter 2008 Business Results 6987 1Interleukin Genetics Announces Conference Call and Webcast to Discuss Second Quarter 2008 Business Results 6987 2
...April 09, 2007 /PRNewswire/ -- Nereus,Pharmaceutic...ment,from marine microbial sources, and its collab...y results involving its cancer drug,candidates at ...l,Meeting in Los Angeles April 14-18. Four posters...hanisms and anti-tumor,activity in several tumor m...
... EXTON, Pa.--(BUSINESS WIRE)--Apr 9, 2007 -,GlaxoS...n,(Nasdaq:ADLR) today announced data from Study 76...velopment program for,alvimopan (Entereg/Entrareg(...controlled (12,month) study, was designed to evalu...opan 0.5 mg twice daily in patients taking,opioids...
Other Medicine Technology:Nereus Pharmaceuticals to Present Data at the American Association,for Cancer Research 2007 Annual Meeting 2Nereus Pharmaceuticals to Present Data at the American Association,for Cancer Research 2007 Annual Meeting 3Nereus Pharmaceuticals to Present Data at the American Association,for Cancer Research 2007 Annual Meeting 4Nereus Pharmaceuticals to Present Data at the American Association,for Cancer Research 2007 Annual Meeting 5GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 2GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 3GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 4GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 5GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 6GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 7
Merocel Ophthalmic Products provide the surgeon with superior fiber free products for unparalleled fluid control and safe cleaning of fine microsurgical instruments. The exclusive Merocel material is
Merocel Ophthalmic Products provide the surgeon with fiber free products for fluid,control and safe cleaning of fine microsurgical instruments. The exclusive Merocel,material is highly absorbent,
Hard protective shields for post-operative or post-injury use. Universal, or Left/Right specific. Packaged 12 per box.
Hard protective shields for post-operative or post-injury use. Universal, or Left/Right specific. Packaged 12 per box.
Medicine Products: